Restore Stability in Your Life
VYRSA™ SI JOINT FUSION
With Long-Term Relief From Chronic Sacroiliac Joint Pain.
Nevro announces acquisition of Vyrsa
Nevro HFX™ 10 kHz Therapy™
One comprehensive solution for individualized relief of chronic pain that gives you more versatility than ever before.
Target the root cause of SI joint pain with patented technology.
The VYRSA™ V1, now Nevro1™, implant may offer a solution to chronic SI joint pain by securely stabilizing the SI joint. The proprietary implant design allows for a reduction in motion and abnormal stress on the SI joint without open surgery. Through a minimally invasive approach, the implant can be securely placed and may relieve pain and restore functionality to individuals suffering from chronic SI joint pain.
WHY VYRSA™?
Procedure Benefits
-
Minimally invasive SI fusion involves smaller incisions, resulting in less disruption to surrounding tissues and muscles and minimal scarring.
-
Minimally invasive techniques are associated with lower rates of complications such as infection, bleeding, and nerve damage due to the smaller incisions and less invasive approach.
-
Minimally invasive SI fusion may result in less post-operative pain compared to open surgery. This can lead to a more comfortable recovery period and reduce the need for strong pain medications.
-
Minimally invasive procedures are often associated with higher patient satisfaction due to the benefits mentioned above, including reduced pain, shorter recovery time, and better cosmetic outcomes.
-
Numerous studies have shown that minimally invasive SI fusion can achieve comparable long-term outcomes to open surgery in terms of pain relief and functional improvement, making it a viable option for patients seeking a durable solution for SI joint dysfunction.
Discover Freedom from SI Joint Pain
Promising Patient Outcomes
Patient outcomes for sacroiliac joint (SIJ) fusion have been consistently positive according to published data. Several studies have demonstrated significant improvements in pain relief, functional outcomes, and patient satisfaction.
In a systematic review by Polly et al. (2019) that included 17 studies and 1,227 patients, SIJ fusion was found to provide substantial pain reduction in patients with chronic SIJ dysfunction. The review reported a mean pain reduction of 73% post-fusion, with 83% of patients achieving a clinically significant improvement in pain scores (PMID: 30589972).
Hermans, Sem M M et al. “Minimally Invasive Sacroiliac Joint Fusion vs Conservative Management in Patients With Sacroiliac Joint Dysfunction: A Systematic Review and Meta-Analysis.” International journal of spine surgery vol. 16,3 (2022): 472-480. doi:10.14444/8241
The Future of SI Joint Fusion Has Arrived.
VYRSA™ PHYSICIANS
VYRSA™ Technologies has disrupted the SI joint fusion implant landscape by developing the FDA-cleared V1 implant technology. Now, this is part of the Nevro™ Portfolio. This innovative solution, supported by a rigorous 2-year biomechanics study, may improve patient outcomes while reducing surgical complications, addressing the frustrations of physicians and advancing the field.
